EndeavorRx, the FDA De Novo-authorized video game digital therapeutic for children with ADHD, is getting a slew of new gameplay features, its developer Akili Interactive announced today. EndeavorRx ...

The team at Akili describes its ethos on its website as “establishing a new era of cognitive medicine.” The company writes it “[believes] effective medicine can also be fun and engaging [by] creating ...

In the wake of study results showing that its video-game-based treatment for symptoms of attention-deficit/hyperactivity disorder (ADHD) could be highly effective in ...

Following positive top-line data released in May, Akili Interactive announced it will release its video game treatment for attention deficit hyperactivity disorder to adults who want to use it.

Less than a week after FDA opened the faucet for digital health products treating psychiatric conditions during the COVID-19 health crisis, Akili has fast-tracked and released its approval-pending ...

After announcing it would start selling its assets earlier this year and lay off nearly half the company, the medical app developer Akili Interactive has found a willing buyer. Virtual Therapeutics, ...

Akili Interactive on Tuesday announced it will lay off 46% of its staff and evaluate strategic alternatives amid sluggish sales of its video game treatment for attention deficit hyperactivity disorder ...

A year after getting FDA clearance for its video game treatment for ADHD, Akili Interactive CEO Eddie Martucci said he’s happy with the early response from doctors and patients. But the company still ...